In a report released on February 21, Steve Sakwa from Evercore ISI maintained a Buy rating on American Homes (AMH – Research Report), with a ...

The eatertainment brand saw same-store sales fall 7.7% last quarter, and failed to maintain a leverage ratio required by a financing covenant.

In a report released yesterday, Ryan Zimmerman from BTIG reiterated a Buy rating on Globus Medical (GMED – Research Report), with a price ...

Gain exclusive insights into Leonardo DRS's Q4 2024 performance: record bookings, revenue growth, innovation investments, and a robust 2025 outlook.

When we spoke three years ago, your research was focused on the shopping center, net lease and health care subsectors. Is there anything new or different about your coverage universe here in 2025? Mr.

BTIG lowered the firm’s price target on NeoGenomics (NEO) to $17 from $18 and keeps a Buy rating on the shares. Q4 results came in light “at an ...

Morgan Stanley cut shares of Hims & Hers Health (NYSE:HIMS – Free Report) from an overweight rating to an equal weight rating ...

Elon Musk’s 97-billion-dollar bid for OpenAI was soundly rejected by the artificial intelligence startup, which said the company “is not for sale.” ...

On Thursday, BTIG analyst Andrew Harte maintained a Buy rating on Paysafe stock (NYSE:PSFE) with a $26.00 price target. This affirmation came in the wake of reports from Bloomberg that Paysafe is ...